Drug Pipeline

JSB462 Clinical Trials

Name: JSB462 clinical trials — 3 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Top Sponsors

Active Studies by Phase

Phase 2

Phase 1

Active Trials

NCT ID	Title	Condition	Status
Phase 2
NCT06991556	An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult…	Metastatic Hormone-sensitive Prostate Cancer	Recruiting
NCT07047118	A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in…	Prostatic Cancer, Castration-Resistant	Active, Not Recruiting
Phase 1
NCT07174063	A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate…	Metastatic Prostate Cancer (mCRPC)	Recruiting

Sponsors Running JSB462 Trials

Novartis Pharmaceuticals (3)

Disease Areas

Prostate Cancer (2)

Get alerts when JSB462 trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.